Portfolio company
Intabio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops analytical instruments and software for biopharmaceutical firms to perform protein characterisation and quality control during drug development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Redshift Bio
This company manufactures analytical instruments and software for biopharmaceutical firms to measure the structure and concentration of proteins and other biomolecules.
Fida Biosystems
This company develops biophysical analysis platforms for characterising proteins and nanoparticles, serving researchers, biotechnology firms, and pharmaceutical manufacturers to accelerate drug development.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Fluidic Sciences Ltd
This company manufactures microfluidic instruments and consumables for protein interaction analysis and single-cell screening to assist biopharmaceutical researchers with drug discovery.
Constellate Proteomics
This company develops single-molecule protein analysis platforms for biopharmaceutical drug developers to monitor antibody quality and rank cell lines during production.
RNAnalytics
This company develops modular analysis toolkits and software for lipid nanoparticle characterisation to support biotech and pharmaceutical firms developing RNA-based therapies.
ProtaGene
This company provides analytical testing and regulatory services for biopharmaceutical, cell and gene therapy developers throughout the drug development life cycle.
IRUBIS
IRUBIS develops mid-infrared spectroscopy systems for real-time monitoring of bioprocess parameters, providing analytical technology to biopharmaceutical manufacturers and laboratories.
